Literature DB >> 24115811

Endotherapy in chronic pancreatitis.

Manu Tandan1, D Nageshwar Reddy.   

Abstract

Chronic pancreatitis (CP) is a progressive disease with irreversible changes in the pancreas. Patients commonly present with pain and with exocrine or endocrine insufficiency. All therapeutic efforts in CP are directed towards relief of pain as well as the management of associated complications. Endoscopic therapy offers many advantages in patients with CP who present with ductal calculi, strictures, ductal leaks, pseudocyst or associated biliary strictures. Endotherapy offers a high rate of success with low morbidity in properly selected patients. The procedure can be repeated and failed endotherapy is not a hindrance to subsequent surgery. Endoscopic pancreatic sphincterotomy is helpful in patients with CP with minimal ductal changes while minor papilla sphincterotomy provides relief in patients with pancreas divisum and chronic pancreatitis. Extracorporeal shock wave lithotripsy is the standard of care in patients with large pancreatic ductal calculi. Long term follow up has shown pain relief in over 60% of patients. A transpapillary stent placed across the disruption provides relief in over 90% of patients with ductal leaks. Pancreatic ductal strictures are managed by single large bore stents. Multiple stents are placed for refractory strictures. CP associated benign biliary strictures (BBS) are best treated with multiple plastic stents, as the response to a single plastic stent is poor. Covered self expanding metal stents are increasingly being used in the management of BBS though further long term studies are needed. Pseudocysts are best drained endoscopically with a success rate of 80%-95% at most centers. Endosonography (EUS) has added to the therapeutic armamentarium in the management of patients with CP. Drainage of pseudcysts, cannulation of inaccessible pancreatic ducts and celiac ganglion block in patients with intractable pain are all performed using EUS. Endotherapy should be offered as the first line of therapy in properly selected patients with CP who have failed to respond to medical therapy and require intervention.

Entities:  

Keywords:  Chronic pancreatitis; Endoscopic retrograde cholangiopancreatography; Endosonography; Extracorporeal shockwave lithotripsy; Pancreatic sphincterotomy

Mesh:

Year:  2013        PMID: 24115811      PMCID: PMC3787344          DOI: 10.3748/wjg.v19.i37.6156

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

1.  Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study.

Authors:  T Sauerbruch; J Holl; M Sackmann; G Paumgartner
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Antibiotic prophylaxis for GI endoscopy.

Authors:  Subhas Banerjee; Bo Shen; Todd H Baron; Douglas B Nelson; Michelle A Anderson; Brooks D Cash; Jason A Dominitz; S Ian Gan; M Edwyn Harrison; Steven O Ikenberry; Sanjay B Jagannath; David Lichtenstein; Robert D Fanelli; Ken Lee; Trina van Guilder; Leslie E Stewart
Journal:  Gastrointest Endosc       Date:  2008-03-28       Impact factor: 9.427

3.  Routine biliary sphincterotomy may not be indispensable for endoscopic pancreatic sphincterotomy.

Authors:  M H Kim; S J Myung; Y S Kim; H J Kim; D W Seo; S W Nam; J H Ahn; S K Lee; Y I Min
Journal:  Endoscopy       Date:  1998-10       Impact factor: 10.093

Review 4.  Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomised controlled trial.

Authors:  Jean-Marc Dumonceau; Guido Costamagna; Andrea Tringali; Kouroche Vahedi; Myriam Delhaye; Axel Hittelet; Gianluca Spera; Emiliano Giostra; Massimiliano Mutignani; Viviane De Maertelaer; Jacques Devière
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

5.  Endoscopic pancreatic sphincterotomy for pancreas divisum by using a needle-knife or standard pull-type technique: safety and reintervention rates.

Authors:  Augustin Attwell; Gregory Borak; Robert Hawes; Peter Cotton; Joseph Romagnuolo
Journal:  Gastrointest Endosc       Date:  2006-09-01       Impact factor: 9.427

6.  Classification of pancreatitis.

Authors:  M Sarner; P B Cotton
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

Review 7.  Endoscopic management of pancreatic pseudocysts.

Authors:  I J Beckingham; J E Krige; P C Bornman; J Terblanche
Journal:  Br J Surg       Date:  1997-12       Impact factor: 6.939

8.  Treatment of symptomatic distal common bile duct stenosis secondary to chronic pancreatitis: comparison of single vs. multiple simultaneous stents.

Authors:  Marc F Catalano; Jeffrey D Linder; Suku George; Eduardo Alcocer; Joseph E Geenen
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

9.  Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.

Authors:  R A Kozarek
Journal:  Gastrointest Endosc       Date:  1990 Mar-Apr       Impact factor: 9.427

10.  Endoscopic cystenterostomy of nonbulging pancreatic fluid collections.

Authors:  Eduardo Sanchez Cortes; Alain Maalak; Olivier Le Moine; Michel Baize; Myriam Delhaye; Celso Matos; Jacques Devière
Journal:  Gastrointest Endosc       Date:  2002-09       Impact factor: 9.427

View more
  10 in total

Review 1.  Advances in the endoscopic management of pancreatic collections.

Authors:  David Ruiz-Clavijo; Belen González de la Higuera; Juan J Vila
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

2.  Effective treatment of benign biliary strictures with a removable, fully covered, self-expandable metal stent: A prospective, multicenter European study.

Authors:  Arthur Schmidt; Tilman Pickartz; Markus M Lerch; Fabrizio Fanelli; Fausto Fiocca; Pierleone Lucatelli; Fabrizio Cereatti; Albrecht Hoffmeister; Werner van Steenbergen; Matthias Kraft; Benjamin Meier; Karel Caca
Journal:  United European Gastroenterol J       Date:  2016-09-07       Impact factor: 4.623

3.  Bleeding pancreatic pseudoaneurysms: management by angioembolization combined with therapeutic endoscopy.

Authors:  Taina Nykänen; Marianne Udd; Erno K Peltola; Ari Leppäniemi; Leena Kylänpää
Journal:  Surg Endosc       Date:  2016-06-17       Impact factor: 4.584

Review 4.  Endoscopic therapy in chronic pancreatitis: current perspectives.

Authors:  Andrada Seicean; Simona Vultur
Journal:  Clin Exp Gastroenterol       Date:  2014-12-17

5.  Endoscopic Intervention through Endoscopic Retrograde Cholangiopancreatography in the Management of Symptomatic Pancreas Divisum: A Long-Term Follow-Up Study.

Authors:  Yi Lu; Bin Xu; Lu Chen; Li-Ke Bie; Biao Gong
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

Review 6.  Management of Pancreatic Calculi: An Update.

Authors:  Manu Tandan; Rupjyoti Talukdar; Duvvur Nageshwar Reddy
Journal:  Gut Liver       Date:  2016-11-15       Impact factor: 4.519

7.  Prognostic factors of response to endoscopic treatment in painful chronic pancreatitis.

Authors:  Alina Tantau; Alina Mandrutiu; Daniel-Corneliu Leucuta; Lidia Ciobanu; Marcel Tantau
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

8.  Surgery for chronic pancreatitis: the comparison of two high-volume centers reveals lack of a uniform operative management.

Authors:  Niccolò Surci; Claudio Bassi; Roberto Salvia; Giovanni Marchegiani; Luca Casetti; Giacomo Deiro; Christina Bergmann; Dietmar Tamandl; Martin Schindl; Jakob Mühlbacher; Klaus Sahora
Journal:  Langenbecks Arch Surg       Date:  2021-10-01       Impact factor: 3.445

9.  Long-Term Outcomes of Endoscopic Intervention in the Treatment of Symptomatic Pancreas Divisum.

Authors:  Guanjun Zhang; Shengxin Chen; Daya Zhang; Lang Wu; Mingyang Li
Journal:  J Healthc Eng       Date:  2022-04-16       Impact factor: 2.682

10.  Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis.

Authors:  Chang Sun; Mu-Yun Liu; Xiao-Gang Liu; Liang-Hao Hu; Tian Xia; Zhuan Liao; Zhao-Shen Li
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.